The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 19, 2013

Filed:

Jan. 10, 2012
Applicants:

Laxmikant Chhipa, Gujarat, IN;

Shitalkumar Pukharaj Zambad, Gujarat, IN;

Ramesh Gupta, Gujarat, IN;

Davinder Tuli, Gujarat, IN;

Ashok Kasundra, Gujarat, IN;

Siralee Munshi, Gujarat, IN;

M. Amir Siddiqui, Gujarat, IN;

Subrat Kumar Bhattamisra, Gujarat, IN;

C. Dutt, Gujarat, IN;

Vijay Chauthaiwale, Gujarat, IN;

Inventors:

Laxmikant Chhipa, Gujarat, IN;

Shitalkumar Pukharaj Zambad, Gujarat, IN;

Ramesh Gupta, Gujarat, IN;

Davinder Tuli, Gujarat, IN;

Ashok Kasundra, Gujarat, IN;

Siralee Munshi, Gujarat, IN;

M. Amir Siddiqui, Gujarat, IN;

Subrat Kumar Bhattamisra, Gujarat, IN;

C. Dutt, Gujarat, IN;

Vijay Chauthaiwale, Gujarat, IN;

Assignee:

Torrent Pharmaceuticals Ltd., Gujarat State, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/415 (2006.01); A61K 31/4155 (2006.01); A61K 31/4245 (2006.01); A61K 31/506 (2006.01); C07D 231/20 (2006.01); C07D 403/06 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 3/00 (2006.01); A61P 5/14 (2006.01); A61P 17/00 (2006.01); A61P 9/00 (2006.01); A61P 25/24 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention discloses a novel thyroid like compounds of formula (I), wherein RR2, R, Rand Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.


Find Patent Forward Citations

Loading…